Application 206532
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE | SOLUTION;INHALATION | EQ 0.083% BASE;0.017% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206532-001 | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE | EQ 0.083% BASE;0.017% | SOLUTION / INHALATION | 2020-07-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A206532-001 | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | EQ 0.083% BASE;0.017% | SOLUTION / INHALATION | 2020-07-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-12-22 03:56 UTC | 2020-12 | A206532-001 | AN | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A206532-001 | AN | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Aurobindo Pharma Limited | 370516c4-718f-4a71-bdc8-8822060ccefe | 2023-10-31 | Warnings, Adverse reactions | 206532 ANDA206532 65862-906 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65862-906 | Ipratropium Bromide and Albuterol Sulfate | Ipratropium Bromide and Albuterol Sulfate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-906 | Ipratropium Bromide and Albuterol Sulfate | Ipratropium Bromide and Albuterol Sulfate | Aurobindo Pharma Limited | ANDA | Current |